Search clinical trials for: ENDO GIA X-tra Thick reload with Tri Staple Technology

Total 13 results

Rennes University Hospital

Completed

REinforcement of the Pancreas in distaL pAncreatectomY (REPLAY) (REPLAY)

Distal Pancreatectomy (DP)

France
Lexington Medical Inc.

Completed

Endostapler Sleeve Gastrectomy Study

Obesity

United States
Wakayama Medical University

Completed

A Prospective, Multi-center Trial for Reinforced Staple During Distal Pancreatectomy

Pancreatic Neoplasms

Japan
Medtronic - MITG

Completed

A Post-market Study of the Endo GIA™ Reinforced Reload With Tri-Staple™ Technology

Non-emergent, Abdominal or Thoracic Procedures

United Kingdom
Medtronic - MITG

Completed

ENDO GIA™ Stapler With ENDO GIA™ Reload With Tri-Staple™ Technology in a Pulmonary Resection

Lung Cancer

United States
Medtronic - MITG
University of South Florida; Duke University; Providence Medical Research Center

Terminated

Radial Reload Open LAR Case Series

Rectal Cancer | Low Anterior Resection | Proctosigmoid Resection

United States
Medtronic - MITG
Duke University; University Hospitals Cleveland Medical Center

Terminated

Radial Reload Laparoscopic LAR Case Series

Colorectal Cancer

United States
Medtronic - MITG

Terminated

ENDO GIA Stapler With Duet Tissue Reinforcement System (TRS) Used in Pulmonary Resections

Lung Disease

Japan
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Chronic Graft Versus Host Disease | Hematologic and Lymphocytic Disorder | Steroid Refractory Graft Versus Host Disease

United States
OHSU Knight Cancer Institute
Genentech, Inc.; Oregon Health and Science University

Not yet recruiting

Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
National Cancer Institute (NCI)

Not yet recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

B Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Lymphoblastic Lymphoma | Mixed Phenotype Acute Leukemia

United States, Canada, Australia, Puerto Rico, New Zealand
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Primary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditions

United States

Search clinical trials for: ENDO GIA X-tra Thick reload with Tri Staple Technology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations